Prevalence and predictors of peripheral neuropathy after breast cancer treatment.
Mandana KamgarMark K GreenwaldHadeel AssadTheresa A HastertEric M McLaughlinKerryn W RedingElectra D PaskettJennifer W BeaAladdin H ShadyabMarian L NeuhouserRami NassirTracy E CraneKalyan SreeramMichael S SimonPublished in: Cancer medicine (2021)
PN is an important long-term consequence of taxane-based chemotherapy in breast cancer survivors.